#pfizer’s #talzenna Combined with #xtandi Shows Significant Survival Benefits in Metastatic Castration-Resistant #prostatecancer https://www.ipharmacenter.com/post/american-society-of-clinical-oncology-genitourinary-cancers-symposium-asco-gu-2025-in-san-francisc #pharma #pharmaceutical #science #ascogu25 #gu25 #news #media #medicine #oncotwitter #medicalaffairs #medical #patientsafety